From WSJopinion: Everyone wants a scapegoat for the scourge of opioid addiction. But the Johnson & Johnson ruling could have far larger, and more dangerous, consequences by opening a vast new arena for product-liability suits.
The ruling Monday by an Oklahoma judge that Johnson & Johnson must pay $572 million for selling opioids will be cheered by everyone who wants a scapegoat for the scourge of addiction. But the ruling could have far larger, and more dangerous, consequences by opening a vast new arena for product-liability suits.
More than 2,000 states and municipalities have sued opioid makers and distributors in federal litigation in Ohio. Another 250 or so have filed lawsuits in state courts where they hope local judges and juries will...
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Oklahoma judge finds J&J liable in opioid epidemic, orders $572 million damagesAn Oklahoma judge orders Johnson & Johnson to pay $572 million after ruling the drugmaker liable for fueling an opioid epidemic in the state by deceptively marketing painkillers
Leer más »
J&J liable for $572 million in Oklahoma opioid epidemic trial, but shares surgeOklahoma judge finds Johnson & Johnson liable in opioid epidemic, ordering $572 million damages
Leer más »
It Is Too Early for Pharma Investors to Cheer Opioid VerdictHold the celebration: The opioid litigation cloud hanging over drug stocks won’t clear up soon, despite an Oklahoma judge’s ruling that Johnson & Johnson is liable for fueling the opioid crisis.
Leer más »
The Latest: Oklahoma judge finds J&J fueled opioid crisisNORMAN, Okla. (AP) — The Latest on Oklahoma's opioids case against Johnson & Johnson (all times local): 3:10 p.m. An Oklahoma judge has found Johnson & Johnson and its subsidiaries...
Leer más »
Judge rules against Johnson & Johnson in landmark opioid case in OklahomaJohnson & Johnson, which was the only defendant in the seven-week trial, has denied any wrongdoing.
Leer más »
Watch: Oklahoma judge to issue landmark verdict in Johnson & Johnson $17 billion opioid trialJ&J, which marketed the opioid painkillers Duragesic and Nucynta, has denied any wrongdoing.
Leer más »